Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Burden in the HIV-Infected Population in the United States
Meredith S. Shiels, Ruth M. Pfeiffer, Mitchell H. Gail, et al.
JNCI Journal of the National Cancer Institute (2011) Vol. 103, Iss. 9, pp. 753-762
Open Access | Times Cited: 731

Showing 26-50 of 731 citing articles:

Current Prevalence of Major Cancer Risk Factors and Screening Test Use in the United States: Disparities by Education and Race/Ethnicity
Ann Goding Sauer, Rebecca L. Siegel, Ahmedin Jemal, et al.
Cancer Epidemiology Biomarkers & Prevention (2019) Vol. 28, Iss. 4, pp. 629-642
Open Access | Times Cited: 146
Kaposi Sarcoma–Associated Herpesvirus-Associated Malignancies: Epidemiology, Pathogenesis, and Advances in Treatment
Manisha Bhutani, Mark N. Polizzotto, Thomas S. Uldrick, et al.
Seminars in Oncology (2015) Vol. 42, Iss. 2, pp. 223-246
Open Access | Times Cited: 143
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV Working Group
Thomas S. Uldrick, Gwynn Ison, Michelle A. Rudek, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 33, pp. 3774-3780
Open Access | Times Cited: 140
Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma
Melinda S. Schuurman, L.C.G. van den Einden, Leon F.A.G. Massuger, et al.
European Journal of Cancer (2013) Vol. 49, Iss. 18, pp. 3872-3880
Closed Access | Times Cited: 137
Cancer Treatment Disparities in HIV-Infected Individuals in the United States
Gita Suneja, Meredith S. Shiels, Rory Angulo, et al.
Journal of Clinical Oncology (2014) Vol. 32, Iss. 22, pp. 2344-2350
Open Access | Times Cited: 137
Pathogenesis of HIV-Related Lung Disease: Immunity, Infection, and Inflammation
Sushma K. Cribbs, Kristina Crothers, Alison Morris
Physiological Reviews (2019) Vol. 100, Iss. 2, pp. 603-632
Closed Access | Times Cited: 133
Diagnosis and management of lymphomas and other cancers in HIV-infected patients
Antonino Carbone, Emanuela Vaccher, Annunziata Gloghini, et al.
Nature Reviews Clinical Oncology (2014) Vol. 11, Iss. 4, pp. 223-238
Closed Access | Times Cited: 131
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood
Minji Byun, S. Cindy, Arzu Akçay, et al.
The Journal of Experimental Medicine (2013) Vol. 210, Iss. 9, pp. 1743-1759
Open Access | Times Cited: 128
HIV infection, aging, and immune function
Robert Dubrow, Michael J. Silverberg, Lesley S. Park, et al.
Current Opinion in Oncology (2012) Vol. 24, Iss. 5, pp. 506-516
Open Access | Times Cited: 127
Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies
Alan R. Lifson, Harry A. Lando
Current HIV/AIDS Reports (2012) Vol. 9, Iss. 3, pp. 223-230
Closed Access | Times Cited: 124
Impact of the HIV Epidemic on the Incidence Rates of Anal Cancer in the United States
Meredith S. Shiels, Ruth M. Pfeiffer, Anil K. Chaturvedi, et al.
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 20, pp. 1591-1598
Open Access | Times Cited: 124
Risk Factors for Anal Cancer in Persons Infected With HIV: A Nested Case-Control Study in the Swiss HIV Cohort Study
Barbara Bertisch, Silvia Franceschi, M. Lise, et al.
American Journal of Epidemiology (2013) Vol. 178, Iss. 6, pp. 877-884
Open Access | Times Cited: 123
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
Alka Bhatia, Yashwant Kumar
Expert Review of Clinical Immunology (2013) Vol. 10, Iss. 1, pp. 41-62
Closed Access | Times Cited: 123
A lymphomagenic role for HIV beyond immune suppression?
Riccardo Dolcetti, Annunziata Gloghini, Arnaldo Caruso, et al.
Blood (2016) Vol. 127, Iss. 11, pp. 1403-1409
Open Access | Times Cited: 121
Incidence and Timing of Cancer in HIV-Infected Individuals Following Initiation of Combination Antiretroviral Therapy
Elizabeth L. Yanik, Sonia Napravnik, Stephen R. Cole, et al.
Clinical Infectious Diseases (2013) Vol. 57, Iss. 5, pp. 756-764
Open Access | Times Cited: 119
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study
Mark N. Polizzotto, Thomas S. Uldrick, Kathleen M. Wyvill, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 34, pp. 4125-4131
Open Access | Times Cited: 119
Risk of AIDS-Defining Cancers Among HIV-1–Infected Patients in France Between 1992 and 2009: Results From the FHDH-ANRS CO4 Cohort
Mira Hleyhel, Aurélien Belot, Anne‐Marie Bouvier, et al.
Clinical Infectious Diseases (2013) Vol. 57, Iss. 11, pp. 1638-1647
Open Access | Times Cited: 113
Phase II Study of Bevacizumab in Patients With HIV-Associated Kaposi's Sarcoma Receiving Antiretroviral Therapy
Thomas S. Uldrick, Kathleen M. Wyvill, Pallavi Kumar, et al.
Journal of Clinical Oncology (2012) Vol. 30, Iss. 13, pp. 1476-1483
Open Access | Times Cited: 113
Cervical cancer – State of the science: From angiogenesis blockade to checkpoint inhibition
Lindsey E. Minion, Krishnansu S. Tewari
Gynecologic Oncology (2018) Vol. 148, Iss. 3, pp. 609-621
Open Access | Times Cited: 113
The Epidemic of Non–Hodgkin Lymphoma in the United States: Disentangling the Effect of HIV, 1992–2009
Meredith S. Shiels, Eric A. Engels, Martha S. Linet, et al.
Cancer Epidemiology Biomarkers & Prevention (2013) Vol. 22, Iss. 6, pp. 1069-1078
Open Access | Times Cited: 112
Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009
Mira Hleyhel
AIDS (2014) Vol. 28, Iss. 14, pp. 2109-2118
Open Access | Times Cited: 112
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia
Shuo-Chieh Wu, Loretta S. Li, Nadja Kopp, et al.
Cancer Cell (2015) Vol. 28, Iss. 1, pp. 29-41
Open Access | Times Cited: 110
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
Cathy Eng, George J. Chang, Y. Nancy You, et al.
Oncotarget (2014) Vol. 5, Iss. 22, pp. 11133-11142
Open Access | Times Cited: 110
Natural History of Anal vs Oral HPV Infection in HIV-Infected Men and Women
Daniel C. Beachler, Gypsyamber D’Souza, Elizabeth A. Sugar, et al.
The Journal of Infectious Diseases (2013) Vol. 208, Iss. 2, pp. 330-339
Open Access | Times Cited: 108
Human Papillomavirus in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era
Cristina Brickman, Joel M. Palefsky
Current HIV/AIDS Reports (2015) Vol. 12, Iss. 1, pp. 6-15
Closed Access | Times Cited: 105

Scroll to top